Vaccination

BioNTech/Pfizer say vaccine can stand warmer temperatures

Germany's BioNTech and its US partner Pfizer on Friday said tests have shown that their coronavirus vaccine can stand warmer temperatures than initially thought, potentially simplifying the jab's complex cold-chain logistics.

Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Vaccination

Hong Kong fast-tracks approval for China's Sinovac vaccine

Hong Kong's government on Thursday approved the Chinese-made Sinovac coronavirus vaccine after a panel of experts fast-tracked its recommendation despite comparatively low efficacy and limited published data.

Diseases, Conditions, Syndromes

Patient critical after reinfection with S.African variant: study

Doctors in France are treating a critically ill patient infected with the South African coronavirus variant, four months after he recovered from COVID-19, in what study authors said was the first case of its kind.

Vaccination

Bosnia begins vaccinating with Russia's Sputnik V jab

Bosnia started vaccinating against the novel coronavirus on Friday, using Russia's Sputnik V jab, but only medical staff will be inoculated for now, given the small supplies available.

Diseases, Conditions, Syndromes

Contact patterns changed in response to national COVID-19 guidance

The number of daily contacts changed over the course of 2020, following the first lockdown, corresponding to alterations in the COVID-19 guidance, suggests a study among staff and students at the University of Bristol. The ...

page 1 from 40